World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

World Top Biotechnology Companies in 2026
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.

  1. Axsome Therapeutics Inc

    World Rank (Aug-2026)
    2,058
    Market Cap (Aug-2026)
    10.883 Billion USD
    World Rank (Jan-05-2024)
    3,583
    Market Cap (Jan-05-2024)
    3.880 Billion USD
    World Rank (Jul-30-2023)
    6,099
    Market Cap (Jul-30-2023)
    1.818 Billion USD
    World Rank (Dec-25-2022)
    5,910
    Market Cap (Dec-25-2022)
    1.753 Billion USD
    Annual Revenue in USD
    638 Million USD
    Annual Operating Income in USD
    -167 Million USD
    Annual Net Income in USD
    -183 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    AXSOME THERAPEUTICS INC is a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The headquarters is in USA.
    Company Website
    AXSOME THERAPEUTICS INC

  2. Summit Therapeutics

    World Rank (Aug-2026)
    2,098
    Market Cap (Aug-2026)
    10.650 Billion USD
    World Rank (Jan-05-2024)
    5,892
    Market Cap (Jan-05-2024)
    1.889 Billion USD
    World Rank (Jul-30-2023)
    6,946
    Market Cap (Jul-30-2023)
    1.479 Billion USD
    World Rank (Dec-25-2022)
    15,677
    Market Cap (Dec-25-2022)
    0.302 Billion USD
    World Rank (Jan-07-2022)
    17,453
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Net Income in USD
    -1,080 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    SUMMIT THERAPEUTICS

  3. Akeso Inc.

    World Rank (Aug-2026)
    2,105
    Market Cap (Aug-2026)
    10.602 Billion USD
    World Rank (Jan-05-2024)
    3,098
    Market Cap (Jan-05-2024)
    4.668 Billion USD
    World Rank (Jul-30-2023)
    3,179
    Market Cap (Jul-30-2023)
    4.631 Billion USD
    World Rank (Dec-25-2022)
    2,924
    Market Cap (Dec-25-2022)
    4.623 Billion USD
    World Rank (Jan-07-2022)
    4,903
    Market Cap (Jan-07-2022)
    2.95 Billion USD
    Headquarters Country
    China
    Company Profile
    Akeso, Inc. is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide. The headquarters is in China.
    Company Website
    AKESO, INC.

  4. Cytokinetics

    World Rank (Aug-2026)
    2,164
    Market Cap (Aug-2026)
    10.306 Billion USD
    World Rank (Jan-05-2024)
    1,870
    Market Cap (Jan-05-2024)
    8.652 Billion USD
    World Rank (Jul-30-2023)
    4,175
    Market Cap (Jul-30-2023)
    3.180 Billion USD
    World Rank (Dec-25-2022)
    3,096
    Market Cap (Dec-25-2022)
    4.314 Billion USD
    World Rank (Jan-07-2022)
    4,885
    Market Cap (Jan-07-2022)
    2.97 Billion USD
    Annual Revenue in USD
    88 Million USD
    Annual Operating Income in USD
    -612 Million USD
    Annual Net Income in USD
    -785 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Cytokinetics is the Leading Muscle Biology Biopharmaceutical company. The headquarters is in USA.

    Facts About Company

    Cytokinetics Annual Total Revenue for year ending Dec-2022 was 94 million USD and and Net loss for year ending Dec-2022 was -388 million USD.

    Cytokinetics Annual Total Revenue for year ending Dec-2021 was 70 million USD and and Net loss for year ending Dec-2021 was -215 million USD.

    As on 2022, Cytokinetics has 409 employees.

    Company Website
    CYTOKINETICS
    Wikipedia
    Wikipedia

  5. bioMérieux S.A.

    World Rank (Aug-2026)
    2,175
    Market Cap (Aug-2026)
    10.250 Billion USD
    World Rank (Jan-05-2024)
    1,355
    Market Cap (Jan-05-2024)
    12.841 Billion USD
    World Rank (Jul-30-2023)
    1,364
    Market Cap (Jul-30-2023)
    12.835 Billion USD
    World Rank (Dec-25-2022)
    1,305
    Market Cap (Dec-25-2022)
    12.163 Billion USD
    World Rank (Jan-07-2022)
    1,322
    Market Cap (Jan-07-2022)
    15.28 Billion USD
    Annual Revenue in USD
    3,957 Million USD
    Annual Operating Income in USD
    731 Million USD
    Annual Net Income in USD
    498 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    France
    CEO
    Alexandre Merieux
    Yahoo
    Company Profile

    Biotechnology company with headquarters is in France.

    Company Website
    BIOMERIEUX
    Wikipedia
    Wikipedia

  6. Praxis Precision Medicines Inc.

    World Rank (Aug-2026)
    2,178
    Market Cap (Aug-2026)
    10.241 Billion USD
    World Rank (Jan-05-2024)
    17,121
    Market Cap (Jan-05-2024)
    0.232 Billion USD
    World Rank (Jul-30-2023)
    20,456
    Market Cap (Jul-30-2023)
    0.126 Billion USD
    World Rank (Dec-25-2022)
    20,944
    Market Cap (Dec-25-2022)
    0.114 Billion USD
    World Rank (Jan-07-2022)
    10,597
    Market Cap (Jan-07-2022)
    0.81 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -326 Million USD
    Annual Net Income in USD
    -303 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Praxis is a Clinical Stage Biopharmaceutical company translating genetic insights into the development of therapies for patients affected by central nervous system (“CNS”) disorders characterized by neuronal imbalance. The company annual net income is 35.5 million USD. The headquarters is in USA.
    Company Website
    PRAXIS PRECISION MEDICINES, INC.

  7. Protagonist Therapeutics

    World Rank (Aug-2026)
    2,204
    Market Cap (Aug-2026)
    10.036 Billion USD
    World Rank (Jan-05-2024)
    7,332
    Market Cap (Jan-05-2024)
    1.316 Billion USD
    World Rank (Jul-30-2023)
    8,303
    Market Cap (Jul-30-2023)
    1.093 Billion USD
    World Rank (Dec-25-2022)
    12,464
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    7,030
    Market Cap (Jan-07-2022)
    1.66 Billion USD
    Annual Revenue in USD
    46 Million USD
    Annual Operating Income in USD
    -158 Million USD
    Annual Net Income in USD
    -130 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Stuttgart
    Company Profile

    Protagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.

    Facts About Company

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.

    As on 2022, Protagonist Therapeutics has 105 employees.

    Company Website
    PROTAGONIST THERAPEUTICS

  8. Krystal Biotech

    World Rank (Aug-2026)
    2,236
    Market Cap (Aug-2026)
    9.835 Billion USD
    World Rank (Jan-05-2024)
    3,986
    Market Cap (Jan-05-2024)
    3.388 Billion USD
    World Rank (Jul-30-2023)
    4,110
    Market Cap (Jul-30-2023)
    3.259 Billion USD
    World Rank (Dec-25-2022)
    5,498
    Market Cap (Dec-25-2022)
    1.973 Billion USD
    World Rank (Jan-07-2022)
    7,197
    Market Cap (Jan-07-2022)
    1.60 Billion USD
    Annual Revenue in USD
    389 Million USD
    Annual Operating Income in USD
    161 Million USD
    Annual Net Income in USD
    205 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Krystal Biotech is a Clinical Stage Gene Therapy company. It initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications and expanding the use of pioneering STAR-D technology to target and treat other skin conditions as well. The headquarters is in USA.
    Company Website
    KRYSTAL BIOTECH

  9. Nuvalent Inc.

    World Rank (Aug-2026)
    2,239
    Market Cap (Aug-2026)
    9.830 Billion USD
    World Rank (Jan-05-2024)
    3,133
    Market Cap (Jan-05-2024)
    4.610 Billion USD
    World Rank (Jul-30-2023)
    4,632
    Market Cap (Jul-30-2023)
    2.756 Billion USD
    World Rank (Dec-25-2022)
    6,273
    Market Cap (Dec-25-2022)
    1.605 Billion USD
    World Rank (Jan-07-2022)
    11,341
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Annual Operating Income in USD
    -414 Million USD
    Annual Net Income in USD
    -425 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Nuvalent, Inc., is a clinical stage biopharmaceutical company, and it develops therapies for patients with cancer.

    The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts, USA.

    Company Website
    NUVALENT, INC.

  10. Kymera Therapeutics Inc.

    World Rank (Aug-2026)
    2,250
    Market Cap (Aug-2026)
    9.761 Billion USD
    World Rank (Jan-05-2024)
    6,735
    Market Cap (Jan-05-2024)
    1.510 Billion USD
    World Rank (Jul-30-2023)
    7,820
    Market Cap (Jul-30-2023)
    1.208 Billion USD
    World Rank (Dec-25-2022)
    6,679
    Market Cap (Dec-25-2022)
    1.453 Billion USD
    World Rank (Jan-07-2022)
    5,018
    Market Cap (Jan-07-2022)
    2.86 Billion USD
    Annual Revenue in USD
    39 Million USD
    Annual Operating Income in USD
    -349 Million USD
    Annual Net Income in USD
    -311 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kymera is a Biopharmaceutical company. It is a developing novel protein degrader therapeutics to treat disease in powerful new ways which harness the body's natural protein degradation system to selectively degrade disease causing proteins with the goal of completely removing them from the body. The company annual revenue is 10.4 million USD and 67 employees as on 2019. The headquarters is in USA.
    Company Website
    KYMERA THERAPEUTICS, INC.

Share